Treace Medical Concepts, Inc.
As of Oct 22, 2026, Treace Medical Concepts is in Stage 3, the topping phase, now in its first week (since Oct 19, 2026). It closed at $4.28, 37.7% below its 52-week high and above its 200-day average, which is rising.
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is TMCI early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
TMCI among Medical Devices78th of 141 by relative strength
All 141 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | TXG | Stage 2 · wk 48 | 99 | −7.8% |
| 2 | RCEL | Stage 2 · wk 13 | 98 | +40.8% |
| 3 | BFLY | Stage 2 · wk 26 | 98 | −26.0% |
| 4 | HAE | Stage 2 · wk 17 | 96 | +8.7% |
| 5 | GKOS | Stage 2 · wk 25 | 96 | +15.1% |
| 6 | AXGN | Stage 3 · wk 2 | 95 | −15.3% |
| 7 | NEOG | Stage 2 · wk 14 | 95 | −11.7% |
| 8 | BVS | Stage 2 · wk 15 | 95 | +10.5% |
| …78 | TMCI | Stage 3 · wk 1 | 29 | −5.1% |
Treace Medical Concepts: quick answers
What stage is Treace Medical Concepts in?
As of Oct 22, 2026, Treace Medical Concepts (TMCI) is in Stage 3, the topping phase. It entered Stage 3 on Oct 19, 2026 and is in its first week there. What the four stages mean
Is Treace Medical Concepts in an uptrend?
Its uptrend has stalled. Treace Medical Concepts is in Stage 3, the topping phase that follows an advance. It trades 34.5% above its 200-day average, which is rising.
How far is Treace Medical Concepts from its 52-week high?
Treace Medical Concepts closed at $4.28 on Oct 22, 2026, 37.7% below its 52-week high of $6.87. Its 52-week low is $1.20.
How has Treace Medical Concepts performed over the past year?
As of Oct 22, 2026, Treace Medical Concepts is down 38.4% over the past year and up 71.2% so far in 2026.
Which sector and industry is Treace Medical Concepts in?
Treace Medical Concepts is in the Medical Devices industry, part of the Health Care sector.
About this companyHealth Care· Medical Devices
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.